Search
Befetupitant
go.drugbank.com/drugs/DB21149ExperimentalBefetupitant is a small molecule drug. The usage of the INN stem '-pitant' in the name indicates that Befetupitant is a neurokinin NK1 (substance P) receptor antagonist.
Edonentan anhydrous
go.drugbank.com/drugs/DB21170ExperimentalEdonentan anhydrous is a small molecule drug. The usage of the INN stem '-entan' in the name indicates that Edonentan anhydrous is a endothelin receptor antagonist.
Tuvatidine
go.drugbank.com/drugs/DB21229ExperimentalTuvatidine is a small molecule drug. The usage of the INN stem '-tidine' in the name indicates that Tuvatidine is a histamine- H2-receptor antagonist, cimetidine derivative.
Octaverine
go.drugbank.com/drugs/DB21449ExperimentalOctaverine is a small molecule drug. The usage of the INN stem '-verine' in the name indicates that Octaverine is a spasmolytic with a papaverine-like action.
Icanbelimod
go.drugbank.com/drugs/DB21572ExperimentalIcanbelimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Icanbelimod is a immunomodulator, both stimulant/suppressive and stimulant.
Uplarafenib
go.drugbank.com/drugs/DB21661ExperimentalUplarafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Uplarafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.
Fosrolapitant
go.drugbank.com/drugs/DB21723InvestigationalFosrolapitant is a small molecule drug. The usage of the INN stem '-pitant' in the name indicates that Fosrolapitant is a neurokinin NK1 (substance P) receptor antagonist.
Flezurafenib
go.drugbank.com/drugs/DB21725ExperimentalFlezurafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Flezurafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor.
COVID-19 Spike-GM-CSF Protein Lactated Ringer's Injection
go.drugbank.com/drugs/DB16520ExperimentalCOVID-19 Spike-GM-CSF Protein Lactated Ringer's Injection is an intradermal injection currently being investigated in the clinical trial NCT03348670 (Discovery Stage (Proof-of-concept) COVID-19 Antigen
Mycobacterium w. Vaccine
go.drugbank.com/drugs/DB15798InvestigationalIt has protective efficacy against M. tuberculosis and M. leprae. As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials. … As an immunotherapy, M.w is used against leprosy; the compound also shares antigens with M. tuberculosis.